Tempus AI Surges 15% in Nasdaq Debut, Valued at $6.65 Billion
Tempus AI rose 15% in its Nasdaq debut, reaching a $6.65B valuation. The company uses AI to enhance medical test accuracy and treatment.
Sunway Healthcare and AstraZeneca Sign Landmark MOU
Sunway Healthcare and AstraZeneca signed an MOU to enhance clinical trials, research, and healthcare services in a groundbreaking partnership.
Recent Posts
Xiaomi Adds DeepSeek AI to HyperOS
February 16, 2025
AI Tools Boost Quality of Life for Most
February 16, 2025
AI Fuels Crypto Surge, Bitcoin Hits $64K
February 16, 2025
Digital Safety for Kids: A New Priority
February 16, 2025
Meta’s New Undersea Cable to Connect US &
February 16, 2025
Dynamic Island vs Now Bar: iOS and Android
February 16, 2025
Apple iPhone 17 Pro Max Rumored Features
February 16, 2025
DeepSeek’s AI Breakthrough Cuts Costs
February 16, 2025
AMD Powers the Future of Gaming
February 16, 2025
Bitcoin’s Weekend Consolidation and Trends
February 16, 2025